Small molecule displacement of a cryptic degron causes conditional protein degradation

The ability to rapidly regulate the functions of specific proteins in living cells is a valuable tool for biological research. Here we describe a novel technique by which the degradation of a specific protein is induced by a small molecule. A protein of interest is fused to a Ligand-Induced Degradation (LID) domain resulting in the expression of a stable and functional fusion protein. The LID domain is comprised of the FK506- and rapamycin-binding protein (FKBP) and a 19-amino acid degron fused to the C-terminus of FKBP. In the absence of the small molecule Shield-1, the degron binds to the FKBP protein and the fusion protein is stable. Shield-1 binds tightly to FKBP thereby displacing the degron and inducing rapid and processive degradation of the LID domain and any fused partner protein. Structure-function studies of the 19-residue peptide showed that a four-amino acid sequence within the peptide is responsible for degradation.

[1]  S. Snyder,et al.  FKBP12 Binds the Inositol 1,4,5-Trisphosphate Receptor at Leucine-Proline (1400–1401) and Anchors Calcineurin to this FK506-like Domain* , 1997, The Journal of Biological Chemistry.

[2]  L. Rozamus,et al.  Investigating protein-ligand interactions with a mutant FKBP possessing a designed specificity pocket. , 2000, Journal of medicinal chemistry.

[3]  John Calvin Reed,et al.  Method for targeting protein destruction by using a ubiquitin-independent, proteasome-mediated degradation pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Wandless,et al.  A general chemical method to regulate protein stability in the mammalian central nervous system. , 2010, Chemistry & biology.

[5]  T. Wandless,et al.  Quantitative analyses of bifunctional molecules. , 2004, Biochemistry.

[6]  J. Mullins,et al.  Conditional transgenic technologies. , 2001, The Journal of endocrinology.

[7]  T. Lawson,et al.  Identification and Characterization of a Protein Destruction Signal in the Encephalomyocarditis Virus 3C Protease* , 1999, The Journal of Biological Chemistry.

[8]  D. S. Garrett,et al.  Identification by NMR of the binding surface for the histidine-containing phosphocarrier protein HPr on the N-terminal domain of enzyme I of the Escherichia coli phosphotransferase system. , 1997, Biochemistry.

[9]  A. Murray,et al.  Cyclin is degraded by the ubiquitin pathway , 1991, Nature.

[10]  Julie A. Theriot,et al.  Actin microfilament dynamics in locomoting cells , 1991, Nature.

[11]  Tatsuo Fukagawa,et al.  An auxin-based degron system for the rapid depletion of proteins in nonplant cells , 2009, Nature Methods.

[12]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[13]  H. Schöler,et al.  Germline‐specific expression of the Oct‐4/green fluorescent protein (GFP) transgene in mice , 1999, Development, growth & differentiation.

[14]  C. Crews,et al.  Chemical Inducers of Targeted Protein Degradation* , 2010, The Journal of Biological Chemistry.

[15]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[16]  P. Howley,et al.  Harnessing the ubiquitination machinery to target the degradation of specific cellular proteins. , 2000, Molecular cell.

[17]  L. Banaszynski,et al.  Conditional control of protein function , 2006, Chemistry & biology.

[18]  Jon Clardy,et al.  DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS AND THE X-RAY CRYSTAL-STRUCTURES OF THEIR COMPLEXES WITH FKBP12. , 1994 .

[19]  S. Schreiber,et al.  A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.

[20]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[21]  R. G. Kulka,et al.  Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae , 1998, The EMBO journal.

[22]  D Rodbard,et al.  An exact correction to the "Cheng-Prusoff" correction. , 1988, Journal of receptor research.

[23]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[24]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[25]  R. Deshaies,et al.  Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Banaszynski,et al.  A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules , 2006, Cell.

[27]  T. Wandless,et al.  Synthesis and analysis of stabilizing ligands for FKBP-derived destabilizing domains. , 2008, Bioorganic & Medicinal Chemistry Letters.

[28]  R. Vierstra,et al.  Redirecting the specificity of ubiquitination by modifying ubiquitin-conjugating enzymes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Shannon R. Magari,et al.  Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Gossen,et al.  Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Schreiber,et al.  Substrate specificity for the human rotamase FKBP: a view of FK506 and rapamycin as leucine-(twisted amide)-proline mimics , 1990 .

[32]  A. Tanaka.  [A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.